Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1965 1
1976 2
1977 2
1978 4
1979 4
1980 4
1981 3
1982 4
1983 2
1984 7
1985 15
1986 15
1987 10
1988 9
1989 8
1990 4
1991 8
1992 11
1993 8
1994 3
1995 13
1996 5
1997 9
1998 14
1999 18
2000 9
2001 13
2002 16
2003 30
2004 36
2005 15
2006 23
2007 24
2008 22
2009 26
2010 36
2011 37
2012 37
2013 35
2014 38
2015 36
2016 35
2017 35
2018 33
2019 25
2020 23
2021 19
2022 14
2023 14
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

747 results

Results by year

Filters applied: . Clear all
Page 1
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial.
Saji H, Okada M, Tsuboi M, Nakajima R, Suzuki K, Aokage K, Aoki T, Okami J, Yoshino I, Ito H, Okumura N, Yamaguchi M, Ikeda N, Wakabayashi M, Nakamura K, Fukuda H, Nakamura S, Mitsudomi T, Watanabe SI, Asamura H; West Japan Oncology Group and Japan Clinical Oncology Group. Saji H, et al. Lancet. 2022 Apr 23;399(10335):1607-1617. doi: 10.1016/S0140-6736(21)02333-3. Lancet. 2022. PMID: 35461558 Clinical Trial.
Segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less including ground-glass opacity (JCOG1211): a multicentre, single-arm, confirmatory, phase 3 trial.
Aokage K, Suzuki K, Saji H, Wakabayashi M, Kataoka T, Sekino Y, Fukuda H, Endo M, Hattori A, Mimae T, Miyoshi T, Isaka M, Yoshioka H, Nakajima R, Nakagawa K, Okami J, Ito H, Kuroda H, Tsuboi M, Okumura N, Takahama M, Ohde Y, Aoki T, Tsutani Y, Okada M, Watanabe SI; Japan Clinical Oncology Group. Aokage K, et al. Among authors: saji h. Lancet Respir Med. 2023 Jun;11(6):540-549. doi: 10.1016/S2213-2600(23)00041-3. Epub 2023 Mar 6. Lancet Respir Med. 2023. PMID: 36893780 Clinical Trial.
A more efficient method to generate integration-free human iPS cells.
Okita K, Matsumura Y, Sato Y, Okada A, Morizane A, Okamoto S, Hong H, Nakagawa M, Tanabe K, Tezuka K, Shibata T, Kunisada T, Takahashi M, Takahashi J, Saji H, Yamanaka S. Okita K, et al. Among authors: saji h. Nat Methods. 2011 May;8(5):409-12. doi: 10.1038/nmeth.1591. Epub 2011 Apr 3. Nat Methods. 2011. PMID: 21460823 Free article.
A single-arm study of sublobar resection for ground-glass opacity dominant peripheral lung cancer.
Suzuki K, Watanabe SI, Wakabayashi M, Saji H, Aokage K, Moriya Y, Yoshino I, Tsuboi M, Nakamura S, Nakamura K, Mitsudomi T, Asamura H; West Japan Oncology Group and Japan Clinical Oncology Group. Suzuki K, et al. Among authors: saji h. J Thorac Cardiovasc Surg. 2022 Jan;163(1):289-301.e2. doi: 10.1016/j.jtcvs.2020.09.146. Epub 2020 Nov 12. J Thorac Cardiovasc Surg. 2022. PMID: 33487427 Free article.
Comparison of pulmonary segmentectomy and lobectomy: Safety results of a randomized trial.
Suzuki K, Saji H, Aokage K, Watanabe SI, Okada M, Mizusawa J, Nakajima R, Tsuboi M, Nakamura S, Nakamura K, Mitsudomi T, Asamura H; West Japan Oncology Group; Japan Clinical Oncology Group. Suzuki K, et al. Among authors: saji h. J Thorac Cardiovasc Surg. 2019 Sep;158(3):895-907. doi: 10.1016/j.jtcvs.2019.03.090. Epub 2019 Apr 9. J Thorac Cardiovasc Surg. 2019. PMID: 31078312 Free article. Clinical Trial.
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer with radiologically pure-solid appearance in Japan (JCOG0802/WJOG4607L): a post-hoc supplemental analysis of a multicentre, open-label, phase 3 trial.
Hattori A, Suzuki K, Takamochi K, Wakabayashi M, Sekino Y, Tsutani Y, Nakajima R, Aokage K, Saji H, Tsuboi M, Okada M, Asamura H, Nakamura K, Fukuda H, Watanabe SI; Japan Clinical Oncology Group; West Japan Oncology Group. Hattori A, et al. Among authors: saji h. Lancet Respir Med. 2024 Feb;12(2):105-116. doi: 10.1016/S2213-2600(23)00382-X. Epub 2024 Jan 3. Lancet Respir Med. 2024. PMID: 38184010 Clinical Trial.
In Vivo Molecular Imaging.
Saji H. Saji H. Biol Pharm Bull. 2017;40(10):1605-1615. doi: 10.1248/bpb.b17-00505. Biol Pharm Bull. 2017. PMID: 28966233 Free article. Review.
Thoracic and cardiovascular surgeries in Japan during 2019 : Annual report by the Japanese Association for Thoracic Surgery.
Committee for Scientific Affairs, The Japanese Association for Thoracic Surgery; Minatoya K, Sato Y, Toh Y, Abe T, Endo S, Hirata Y, Ishida M, Iwata H, Kamei T, Kawaharada N, Kawamoto S, Kohno K, Kumamaru H, Matsumiya G, Motomura N, Nakahara R, Okada M, Saji H, Saito A, Shimizu H, Suzuki K, Takemura H, Taketani T, Takeuchi H, Tatsuishi W, Yamamoto H, Yasuda T, Watanabe M, Yoshimura N, Tsuchida M, Sawa Y. Committee for Scientific Affairs, The Japanese Association for Thoracic Surgery, et al. Among authors: saji h. Gen Thorac Cardiovasc Surg. 2023 Oct;71(10):595-628. doi: 10.1007/s11748-023-01945-4. Epub 2023 Jul 20. Gen Thorac Cardiovasc Surg. 2023. PMID: 37470949 Free PMC article. Review. No abstract available.
Current status of clinical proteogenomics in lung cancer.
Nishimura T, Nakamura H, Végvári Á, Marko-Varga G, Furuya N, Saji H. Nishimura T, et al. Among authors: saji h. Expert Rev Proteomics. 2019 Sep;16(9):761-772. doi: 10.1080/14789450.2019.1654861. Epub 2019 Aug 21. Expert Rev Proteomics. 2019. PMID: 31402712 Review.
747 results